{
  "name": "Amgen",
  "slug": "amgen",
  "ticker": "AMGN",
  "fetched_at": "2025-12-07T12:21:15.305192+00:00",
  "news": [
    {
      "title": "Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow - Amgen",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNc0pjZjFhcktfYnNMRFdIb3pOOFR5bXBGQzlzWjQ5WXhuX0dDSUdMRTM5bXZ0cVdPYWRaWUZoX25RVXRmX1EwVTVtblVUcHdSQU12WndmU1d2UWlpSUpBMDVoVnFnLXJGR243LWswYlVXRDJVZlgwLTFDeFFDd0NhYlV3TE8tQTlfNklyRXVfQWdqbkVPNGl2Z1M2TUFnQnp5dW40?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxNc0pjZjFhcktfYnNMRFdIb3pOOFR5bXBGQzlzWjQ5WXhuX0dDSUdMRTM5bXZ0cVdPYWRaWUZoX25RVXRmX1EwVTVtblVUcHdSQU12WndmU1d2UWlpSUpBMDVoVnFnLXJGR243LWswYlVXRDJVZlgwLTFDeFFDd0NhYlV3TE8tQTlfNklyRXVfQWdqbkVPNGl2Z1M2TUFnQnp5dW40?oc=5\" target=\"_blank\">Bio Meets Tech: How Amgen is Designing the Medicines of Tomorrow</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Amgen</font>",
      "published": "2025-12-02T13:00:35+00:00",
      "source": "Amgen"
    },
    {
      "title": "Amgen (NASDAQ:AMGN) Cut to \"Buy\" at Wall Street Zen - MarketBeat",
      "link": "https://news.google.com/rss/articles/CBMiogFBVV95cUxPZmU0M1pNWVRzRTgwZFNlU08xQjJmQ3hPWWZrSkVuMW1LT3piUkVsUm42NnpndUlpb01lWDk5czdMaXpiMVVSb04wYjJCYzkxWFJORUhldGVXWHNqWW5pSm1wcTUyUFF6U1FtZFZoZVBoUEhYR1A0RC16YjFXRF9lLTlRRUNJNVU0c3E0M0ZHeU9KQ3ZCekFKVjlIMW9yRjJYUnc?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiogFBVV95cUxPZmU0M1pNWVRzRTgwZFNlU08xQjJmQ3hPWWZrSkVuMW1LT3piUkVsUm42NnpndUlpb01lWDk5czdMaXpiMVVSb04wYjJCYzkxWFJORUhldGVXWHNqWW5pSm1wcTUyUFF6U1FtZFZoZVBoUEhYR1A0RC16YjFXRF9lLTlRRUNJNVU0c3E0M0ZHeU9KQ3ZCekFKVjlIMW9yRjJYUnc?oc=5\" target=\"_blank\">Amgen (NASDAQ:AMGN) Cut to \"Buy\" at Wall Street Zen</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">MarketBeat</font>",
      "published": "2025-12-07T06:13:37+00:00",
      "source": "MarketBeat"
    },
    {
      "title": "Why Is Amgen (AMGN) Up 8% Since Last Earnings Report? - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMid0FVX3lxTE9abjlYSlh2YUozNU0zNjFQZ1ZXSlVaTjRVRU9TZEpuME90LXF3MkJDaFhaNnlBaHI5R3pjQWVkU1BPcW9KV1VQRjR4SG9LTHVnemdFcEZlOTFkQjRzM19SZHBrNlFRZDJsZmJVWnE0a1phTlFlZzE0?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMid0FVX3lxTE9abjlYSlh2YUozNU0zNjFQZ1ZXSlVaTjRVRU9TZEpuME90LXF3MkJDaFhaNnlBaHI5R3pjQWVkU1BPcW9KV1VQRjR4SG9LTHVnemdFcEZlOTFkQjRzM19SZHBrNlFRZDJsZmJVWnE0a1phTlFlZzE0?oc=5\" target=\"_blank\">Why Is Amgen (AMGN) Up 8% Since Last Earnings Report?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-12-04T16:30:07+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens - Insider Monkey",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">BMO Capital Lifts Amgen (AMGN) Price Target as MariTide Outlook Strengthens</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Insider Monkey</font>",
      "published": "2025-12-06T18:51:47+00:00",
      "source": "Insider Monkey"
    },
    {
      "title": "A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain - simplywall.st",
      "link": "https://news.google.com/rss/articles/CBMi1AFBVV95cUxPbkV2LU04a3RVOGczVVFlRmdFWUpkMFFKQm1NaldfWGpTaEU2LXNieTczQ096R05hS1Y5V0t0LWRGa2kzT3hLT3E3WVp5R001WWhnRVNLRTMtU0ttbDJ5bzM0RHppXzFpZlJjVkI2Qk5BbHBlemZ6bkJyX3ZWejlyZ0hZQWliQ0J5eG9xOElyLUNLNXFORnpkRjdHV1lvNjNfbG1ibGlKclE0RVgyVkxDNnltNmMzdzQ3bTRqZEp5X1lGX040OS11Q2ZNeDZwZWhIajVoZNIB2gFBVV95cUxOTzZwaDdqNjlNN2Y2dUVldXZYdHVDdVRSOWNZNm5vTkQxZHJzLURZYXY2RUlWbjJaWVdjUm5FZ09LSzBKVzlJczBCVUVPOE9KVjNnaTdQdWo4UXJjMVp2VXI0M0dqMTREWUR5TllrTEJLQTlENFp4VG1mMk5hNElrVzFmSXZ6NWFVVTFDU1JuNEpFck9wTWdTUHQ2OGpNbzN1TXZjQ1BKcExpbGdRb1pfUG80Z2dyNjZUM1dNWFFhYTlScTVuUjJzbGNUaC12MFR2MGJHVXpPeHJLQQ?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Closer Look at Amgen (AMGN) Valuation After Its 12-Month 28% Share Price Gain</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-12-05T18:48:38+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "Amgen: Stagnation And The IRS Are Coming (NASDAQ:AMGN) - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMihwFBVV95cUxPdEl1S2JIRi1hWGhGWXJKNFZNbjVWZmhGblgybTlDd09mczhkbmd5d1EzRkRpN19zQ2ZvVzl4ZjBmbFZfT0d0cUtkNlozZHFqY3FjR2hvZnJ6Q2RsRjZQYURaZVBCOGMzbDIta3NwRHFSNEdJRVcyUWlZVkZRQkVrQkxDZEtMUWs?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihwFBVV95cUxPdEl1S2JIRi1hWGhGWXJKNFZNbjVWZmhGblgybTlDd09mczhkbmd5d1EzRkRpN19zQ2ZvVzl4ZjBmbFZfT0d0cUtkNlozZHFqY3FjR2hvZnJ6Q2RsRjZQYURaZVBCOGMzbDIta3NwRHFSNEdJRVcyUWlZVkZRQkVrQkxDZEtMUWs?oc=5\" target=\"_blank\">Amgen: Stagnation And The IRS Are Coming (NASDAQ:AMGN)</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-12-04T14:25:03+00:00",
      "source": "Seeking Alpha"
    },
    {
      "title": "Does Amgen Stock Lead the Pack? - Trefis",
      "link": "https://news.google.com/rss/articles/CBMiowFBVV95cUxNQnJYaDU3NjU5ekc3akZ1Sl9TeVdxM3FRZW9ROEJDcnY1VEJNOGpXXy1kWi03d0VfclphT1FkWHhBQ0pTdlB5REVJS0FJWVZzb095cVVMakEyeE95Zy0zbmxvWHItTzNuTWFCZUtaN2llc2ZRUDg4YTY3YjNSSjEtcGFHcDVHTmpoa3g0eDBMaXg2X0xIZkJKaVBVX1Fyekhuc2Qw?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiowFBVV95cUxNQnJYaDU3NjU5ekc3akZ1Sl9TeVdxM3FRZW9ROEJDcnY1VEJNOGpXXy1kWi03d0VfclphT1FkWHhBQ0pTdlB5REVJS0FJWVZzb095cVVMakEyeE95Zy0zbmxvWHItTzNuTWFCZUtaN2llc2ZRUDg4YTY3YjNSSjEtcGFHcDVHTmpoa3g0eDBMaXg2X0xIZkJKaVBVX1Fyekhuc2Qw?oc=5\" target=\"_blank\">Does Amgen Stock Lead the Pack?</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Trefis</font>",
      "published": "2025-12-04T11:59:16+00:00",
      "source": "Trefis"
    },
    {
      "title": "CEO of drugmaker Amgen talks new results from cholesterol drug trial - CNBC",
      "link": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNWnIyMTBzWlF3YTBDeVhfYlNYcnZBZ2RzQWpOamRxb3JSZU55MEdrUDRqdzZGT2o3VGNxa05Pc21hUThTZW9pS3lSWmFNWHZfaXJ0YmNodTVXNFhjM2hYZjBWeVpkSlVCakJHczRtOV94aWt2VlJQaU8zQWxCenZvZ1cyVmlJUDJSQUwzd0xZallhcldodk1jUjdnRk5RbkY3VUNPb29fWjLSAa4BQVVfeXFMTndXUncyNjdFRlpKT21TbEFRV2pMY1lDeTdEQ3NNcFlzLV9ScTJJZjFGdDRTWElDbHNGRXkwSkFMVFBxZVFQZzVDRWZmYVlJcEYxOVR6dGtKcEpOVDBlWXRSQVVxSGFnMUxxd2pMaTNmWkZGeTBCMVhGZ0lNbkFzNUlmcGZETUtFTXJkX01qblFRSTFHUG9kV3hVa29yWkNXTjFOZkxuNzY5SjZ6REl3?oc=5\" target=\"_blank\">CEO of drugmaker Amgen talks new results from cholesterol drug trial</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">CNBC</font>",
      "published": "2025-11-10T08:00:00+00:00",
      "source": "CNBC"
    }
  ],
  "product_launches": [
    {
      "title": "Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful - BioSpace",
      "link": "https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVEJYNkQ0cURCVTNSd1VIbU1JLWtmblBqXzNDZnp6SVBBcWpGcm5zNWdaUFZwdjN4aGR4TnJoYm9PMWk2STRNdmdKMjRKU2pQVURtamRpUDBja3ZhYk1ONHJRemdtdkpVRHJ3SXBESkdyNG1hMW1ZQW4wb0xpYmMxY0E5RkRyVERkaS1FczJlUmZmbVZRN2VWenB5czdkeFg4eG5jNkZqQm9RU3FaMjl6dl9R?oc=5\" target=\"_blank\">Amgen, Kyowa Kirin Bolster Safety Profile for Atopic Dermatitis Hopeful</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">BioSpace</font>",
      "published": "2025-09-10T07:00:00+00:00",
      "source": "BioSpace"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism - Yahoo Finance",
      "link": "https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMihgFBVV95cUxObWpGcHFxUm1WbnhhdFJUOW1kcjlGamhOQTdxdnVqWVRmQkxzNzdYd0poQk96QVByUENRMHhxQlFhVXctWGhjSWw4bjIzMXoxdFhLaVhpU0xMbnltTjhBejY4X1lQOWJuRENDNjVTbWxRRjZMMERRT0RVLVdETjhUcVljeTM3QQ?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation as Repatha Scores Major Trial Win and Direct Sales Launch Spurs Optimism</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Yahoo Finance</font>",
      "published": "2025-10-16T07:00:00+00:00",
      "source": "Yahoo Finance"
    },
    {
      "title": "A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach - simplywall.st",
      "link": "https://news.google.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?oc=5",
      "summary": "<a href=\"https://news.google.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?oc=5\" target=\"_blank\">A Look at Amgen’s (AMGN) Valuation Following FDA Nod Expanding Repatha’s Patient Reach</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">simplywall.st</font>",
      "published": "2025-09-08T07:00:00+00:00",
      "source": "simplywall.st"
    },
    {
      "title": "3 major patent losses this year — and a key strategy to fill the gaps - PharmaVoice",
      "link": "https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMimgFBVV95cUxPNGpDZTgwdDRLOFozTU9HVGVzWWpkS1dXSEd4X1c0RzVVdktmbzUwVVhWSW01X3BkbGl5c084anVWeHVkX1FEU1pEMm13ZW91WlBwNE5CQVVmYURaaEFOREx0dk1fTTJyT01lYW1ZVXBOV2ZXTTdFamNYc2FVbTAyazJOeEVnNkszUXphcjI5blNXSV9wZ0tmcThR?oc=5\" target=\"_blank\">3 major patent losses this year — and a key strategy to fill the gaps</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">PharmaVoice</font>",
      "published": "2025-07-21T07:00:00+00:00",
      "source": "PharmaVoice"
    },
    {
      "title": "Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns - Seeking Alpha",
      "link": "https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5",
      "summary": "<a href=\"https://news.google.com/rss/articles/CBMivwFBVV95cUxNNldFcDdyVUNrRFhsN2JMUDZuakRJNDN5R0JBNzFfbXNuaGVLVTRubVhsV3l2eEk4MGR2X2xLcXVON3NHVVZOVjZvZHNzdHBsTGVNZEFJaEp2WGRxUnNYdng4TS1yaWNrd1g5bW5tcnNvZUh1QzlleW96akRZUG1tNGRKLXdqdmg5TUdudlpielVzcHd2VUpYa3pfWkJjX0lESEJDc3BET1hFWGtreWdqNEdkNlMtT2dncThfMVVuOA?oc=5\" target=\"_blank\">Amgen: Biosimilars And Rare Disease Pipeline Crucial To Overcome Patent Cliff Concerns</a>&nbsp;&nbsp;<font color=\"#6f6f6f\">Seeking Alpha</font>",
      "published": "2025-07-15T07:00:00+00:00",
      "source": "Seeking Alpha"
    }
  ],
  "stock": {
    "ticker": "AMGN",
    "currency": "USD",
    "latest": {
      "date": "2025-12-05",
      "close": 329.8900146484375
    },
    "history": [
      {
        "date": "2025-11-26",
        "close": 344.57000732421875
      },
      {
        "date": "2025-11-28",
        "close": 345.4599914550781
      },
      {
        "date": "2025-12-01",
        "close": 337.489990234375
      },
      {
        "date": "2025-12-02",
        "close": 338.3599853515625
      },
      {
        "date": "2025-12-03",
        "close": 345.4200134277344
      },
      {
        "date": "2025-12-04",
        "close": 340.1600036621094
      },
      {
        "date": "2025-12-05",
        "close": 329.8900146484375
      }
    ],
    "name": "Amgen Inc."
  }
}